Genovate Biotechnology (Taiwan) Analysis
| 4130 Stock | TWD 21.85 0.05 0.23% |
Genovate Biotechnology Co is overvalued with Real Value of 19.66 and Hype Value of 21.8. The main objective of Genovate Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what Genovate Biotechnology Co is worth, separate from its market price. There are two main types of Genovate Biotechnology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Genovate Biotechnology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Genovate Biotechnology's stock to identify patterns and trends that may indicate its future price movements.
The Genovate Biotechnology stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Genovate Biotechnology is usually not traded on No Trading . Market opens only for Clearing & Settlement, Mid - autumn / Moon Festival, No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2. Genovate Stock trading window is adjusted to Asia/Taipei timezone.
Genovate |
Genovate Stock Analysis Notes
About 27.0% of the company shares are owned by institutions such as pension funds. The book value of Genovate Biotechnology was presently reported as 12.82. The company last dividend was issued on the 20th of July 2022. Genovate Biotechnology had 1000:1030 split on the 20th of August 2024. For more info on Genovate Biotechnology Co please contact the company at 886 3 598 2221 or go to https://www.genovate-bio.com.Genovate Biotechnology Investment Alerts
| Genovate Biotechnology generated a negative expected return over the last 90 days | |
| Genovate Biotechnology generates negative cash flow from operations |
Genovate Biotechnology Thematic Classifications
In addition to having Genovate Biotechnology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services | |
 | ITInformation technology and IT services | |
 | ComputersUSA Equities from Computers industry as classified by Fama & French |
Genovate Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genovate Biotechnology's market, we take the total number of its shares issued and multiply it by Genovate Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Genovate Profitablity
Genovate Biotechnology's profitability indicators refer to fundamental financial ratios that showcase Genovate Biotechnology's ability to generate income relative to its revenue or operating costs. If, let's say, Genovate Biotechnology is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Genovate Biotechnology's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Genovate Biotechnology's profitability requires more research than a typical breakdown of Genovate Biotechnology's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01. Technical Drivers
As of the 26th of November, Genovate Biotechnology retains the Risk Adjusted Performance of (0.03), market risk adjusted performance of 0.6608, and Standard Deviation of 0.8627. Genovate Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genovate Biotechnology standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if Genovate Biotechnology is priced fairly, providing market reflects its last-minute price of 21.85 per share.Genovate Biotechnology Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Genovate Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Genovate Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Genovate Biotechnology Outstanding Bonds
Genovate Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genovate Biotechnology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genovate bonds can be classified according to their maturity, which is the date when Genovate Biotechnology Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Genovate Biotechnology Predictive Daily Indicators
Genovate Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genovate Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 487.53 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 21.88 | |||
| Day Typical Price | 21.87 | |||
| Period Momentum Indicator | 0.05 |
Genovate Biotechnology Forecast Models
Genovate Biotechnology's time-series forecasting models are one of many Genovate Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genovate Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Genovate Biotechnology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.